AT404699T
Nucleotide sequences derived from the genomes of the retroviruses HIV-1, HIV-2 and SIV, and their application to the amplification of pol sequences in these viral genomes and to the in vitro diagnosis of infections resulting from these viruses
Abstract
oligonucleotide characterized in that its sequence consists of: i) a specific sequence of the gag gene or the gene pol, and suitable is, at a temperature of 60 ° C ± 1 ° C to the Genome of the HIV-1 Bru, HIV-1 time, HIV-1 Eli, HIV-2 Rod or SIV Mac hybridize to, or ii) a complementary sequence a sequence as defined in i).
Term
Term ended
Expired 5 June 2010, 16.3 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
72 members in 13 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 8907354 | France | A | |
| 8912371 | France | A |
Members72
| Document | Office | Kind | |
|---|---|---|---|
| CA2062829A1 | Canada | A1 | |
| FR2647809A1 | France | A1 | |
| CA2585164A1 | Canada | A1 | |
| CA2685262A1 | Canada | A1 | |
| WO9015066A2 | World Intellectual Property Organization (WIPO) | A2 | |
| EP0403333A2 | European Patent Office (EPO) | A2 | |
| FR2652091A1 | France | A1 | |
| WO9015066A3 | World Intellectual Property Organization (WIPO) | A3 | |
| FR2647809B1 | France | B1 | |
| EP0403333A3 | European Patent Office (EPO) | A3 | |
| JPH04507043A | Japan | A | |
| FR2652091B1 | France | B1 | |
| EP0806484A2 | European Patent Office (EPO) | A2 | |
| US5688637A | United States of America | A | |
| SG47868A1 | Singapore | A1 | |
| US5786177A | United States of America | A | |
| EP0403333B1 | European Patent Office (EPO) | B1 | |
| AT185379T | Austria | T | |
| ATE185379T1 | Austria | T1 | |
| DE69033311D1 | Germany | D1 | |
| ES2139567T3 | Spain | T3 | |
| DE69033311T2 | Germany | T2 | |
| DK0403333T3 | Denmark | T3 | |
| JP2000093187A | Japan | A | |
| GR3032261T3 | Greece | T3 | |
| EP0806484A3 | European Patent Office (EPO) | A3 | |
| US6194142B1 | United States of America | B1 | |
| JP3428012B2 | Japan | B2 | |
| US2005037340A1 | United States of America | A1 | |
| US2006035260A1 | United States of America | A1 | |
| US7022814B1 | United States of America | B1 | |
| EP1642987A2 | European Patent Office (EPO) | A2 | |
| EP0806484B1 | European Patent Office (EPO) | B1 | |
| AT323183T | Austria | T | |
| ATE323183T1 | Austria | T1 | |
| DE69034220D1 | Germany | D1 | |
| US7078516B1 | United States of America | B1 | |
| DK0806484T3 | Denmark | T3 | |
| EP1642987A3 | European Patent Office (EPO) | A3 | |
| EP1715064A1 | European Patent Office (EPO) | A1 | |
| ES2262166T3 | Spain | T3 | |
| DE69034220T2 | Germany | T2 | |
| HK1092839A1 | Hong Kong, China | A1 | |
| DE05014676T1 | Germany | T1 | |
| EP1715064A8 | European Patent Office (EPO) | A8 | |
| ES2275451T1 | Spain | T1 | |
| HK1097574A1 | Hong Kong, China | A1 | |
| CA2062829C | Canada | C | |
| EP1642987B1 | European Patent Office (EPO) | B1 | |
| AT404699TThis record | Austria | T | |
| ATE404699T1 | Austria | T1 | |
| DE69034260D1 | Germany | D1 | |
| DK1642987T3 | Denmark | T3 | |
| EP2011888A1 | European Patent Office (EPO) | A1 | |
| ES2275451T3 | Spain | T3 | |
| EP1715064B1 | European Patent Office (EPO) | B1 | |
| AT423856T | Austria | T | |
| ATE423856T1 | Austria | T1 | |
| ES2315215T1 | Spain | T1 | |
| DE69034265D1 | Germany | D1 | |
| DE07025195T1 | Germany | T1 | |
| ES2321326T3 | Spain | T3 | |
| DK1715064T3 | Denmark | T3 | |
| HK1125136A1 | Hong Kong, China | A1 | |
| CA2585164C | Canada | C | |
| EP2011888B1 | European Patent Office (EPO) | B1 | |
| AT466111T | Austria | T | |
| ATE466111T1 | Austria | T1 | |
| DE69034267D1 | Germany | D1 | |
| US7759477B2 | United States of America | B2 | |
| DK2011888T3 | Denmark | T3 | |
| US7777020B2 | United States of America | B2 |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Cancelled due to lapse of timeLapsedEELA | EELA | |
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 5014676
Titles2
- German
- NUKLEOTID-SEQUENZEN VON HIV-1, HIV-2 UND SIV RETROVIRUSGENOMEN, IHRE VERWENDUNG ZUR AMPLIFIZIERUNG VON DIESEN RETROVIREN UND ZUR IN VITRO DIAGNOSTIK VON DIESEN VIREN VERURSACHTEN INFEKTIONEN
- English
- NUCLEOTIDE SEQUENCES OF HIV-1, HIV-2 AND SIV RETROVIRUS GENOMES, THEIR USE TO AMPLIFY THESE RETROVIRUSES, AND THE INFECTIONS CAUSED BY VITRO DIAGNOSIS OF THESE VIRUSES
Classification
- CPC, 10
- C07K14/005
- A61K38/00
- A61K39/00
- A61P31/18
- C12N2740/15022
- C12N2740/16022
- C12Q1/703
- G01N2333/16
- Y10S435/974
- Y10S435/975
- IPC, 15
- C12Q1 70
- A61K39 00
- A61K39 21
- A61K48 00
- A61P31 18
- C07H21 04
- C07K14 00
- C07K14 155
- C07K14 16
- C07K16 00
- C07K16 10
- C12N15 09
- C12N15 49
- C12Q1 68
- G01N33 569